Clear Cell Renal Cell Cancer (ccRCC) Clinical Trials

8 clinical trials for Clear Cell Renal Cell Cancer (ccRCC) across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases — RECRUITING · PHASE2
• GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors — RECRUITING · PHASE1
• 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors — RECRUITING · NA
• Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC — RECRUITING · PHASE3
• Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02) — ACTIVE_NOT_RECRUITING
• A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread — NOT_YET_RECRUITING · PHASE2
• First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours — COMPLETED · PHASE1

Refine this search